Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon Oct 26, 2017 10:59am
156 Views
Post# 26862140

FDA ADK !

FDA ADK !When I read the articule below about FDA approving new AI applications ...it makes me smile to think that ADK already has FDA Approval for Diabetic screening...and with Cardio to follow and piggyback on the same platform well one could see how we could become a very quick takeover target ...A few items that caught my eye !

- $30 billion into AI in 2016, with another $9 billion going into AI start-ups.

- The science is unstoppable, and so is the flow of funding. But at least
one roadblock stands in the way...FDA

- FDA now applies to everything from pharmaceuticals to hospital equipment to medical software.

- getting a basic ISO can cost two years and seven figures. “How many investors are going to give you that amount of money just so you can get to the starting line?”

“There’s a reason that tech companies like Google haven’t been going the FDA route.”

- “For those few companies who do make it through, they have an enormous competitive advantage,”

- “We won’t have to worry about the usual scenario: Two guys from Stanford in a garage inventing some app that instantly takes away all our business. We only have to worry about the big players—who might just buy us out instead of competing with us.”


https://webcache.googleusercontent.com/search?q=cache:Axf7IskVxzMJ:https://www.theatlantic.com/technology/archive/2017/10/algorithms-future-of-health-care/543825/+&cd=13&hl=en&ct=clnk&gl=ca



Bullboard Posts